Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001366313 | SCV001562614 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2023-10-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002550059 | SCV003564088 | uncertain significance | Inborn genetic diseases | 2022-06-27 | criteria provided, single submitter | clinical testing | The c.1765G>A (p.A589T) alteration is located in exon 9 (coding exon 8) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 1765, causing the alanine (A) at amino acid position 589 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |